September 28, 2016 2:00 PM ET

Biotechnology

Company Overview of Danube Pharmaceuticals, Inc.

Company Overview

Danube Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the research and development of drugs and technologies for the treatment of ophthalmic and other related diseases. Its DNB-001 is a small molecule for the treatment of glaucoma. The company also engages in the research of efficacy of novel oral therapy with a dual mechanism of action, in lowering the intraocular pressure ("IOP") in patients with ocular hypertension. The company was incorporated in 2005 and is based in New York, New York.

689 Fifth Avenue

14th Floor

New York, NY 10022

United States

Founded in 2005

Phone:

646-375-4641

Fax:

646-375-4651

Key Executives for Danube Pharmaceuticals, Inc.

Chief Executive Officer, Chief Medical Officer and Director
Senior Director of Clinical Operations
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Danube Pharmaceuticals, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.